Top Markets
#1 龙虾 (Lobster) 龙虾 (Lobster) +111.56%
#2 Lisk Lisk +79.88%
#3 Not in Employment, Education, or Training Not in Employment, Education, or Training +32.86%
#4 Tokenlon Tokenlon +28.91%
#5 Nockchain Nockchain +28.07%
#6 Alchemist AI Alchemist AI +25.95%
#7 earnAUSD earnAUSD +24.75%
#8 Illuvium Illuvium +22.65%
#9 Renzo Renzo +21.31%
#10 Akedo Akedo +18.08%
Coin of the day
龙虾 (Lobster) 龙虾 (Lobster)
Setări
Limbă
ROMâNă
Monedă
USD
Temă
MultiCell Technologies, Inc. MultiCell Technologies, Inc.

MultiCell Technologies, Inc.

MCET
Rang în acțiuni #41009
MultiCell Technologies, Inc. (MCET) operates as a biopharmaceutical firm,... MultiCell Technologies, Inc. (MCET) operates as a biopharmaceutical firm, primarily focused on the creation of innovative therapeutic agents and research tools. Their efforts are directed towards addressing a range of medical challenges, including neurological conditions, liver ailments, various types of cancer, and applications within interventional cardiology and peripheral vascular health. The company's product pipeline features several key developments: MCT-125: This investigational therapy is currently in Phase II clinical trials, targeting the primary fatigue commonly associated with multiple sclerosis. MCT-465: A preclinical-stage synthetic double-stranded RNA (dsRNA) candidate, designed to act as a powerful immune enhancer for the treatment of solid tumor malignancies. MCT-485: Another dsRNA therapeutic, still in the discovery phase, which demonstrates tumor cytolytic (cell-destroying) properties, intended for use against diverse cancers. Beyond drug candidates, MultiCell Technologies is also progressing the Ideal BioStent, an innovative bioabsorbable stent specifically engineered for use in interventional cardiology and peripheral vessel procedures. The organization maintains licensing agreements with prominent entities such as Corning Incorporated and Pfizer Inc. Established in 1962, the company was previously known as Exten Industries, Inc. before officially changing its name to MultiCell Technologies, Inc. in April 2004. Its corporate headquarters are situated in Woonsocket, Rhode Island.
Preț acțiune
$0.00001
Ultima sincronizare: 2026-09-10
Capitalizare de piață
$50.01K
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează MultiCell Technologies, Inc. (MCET)

Categorie

Healthcare
EPS pentru MultiCell Technologies, Inc. (MCET)
EPS la data de August 2015 TTM: $0.00
Conform celor mai recente rapoarte financiare și prețului acțiunilor MultiCell Technologies, Inc., EPS-ul actual al companiei (TTM) este $0.00. La sfârșitul anului 2013, compania avea un EPS de $0.00 egal cu EPS-ului din 2026, care a fost de 0.
Istoricul EPS pentru MultiCell Technologies, Inc. din 2013 până în 2026
EPS la sfârșitul fiecărui an
An EPS Schimbă
2026 (TTM) 0.00 -83.33%
2014 0.00 -83.33%
2013 0.00 0.00%
EPS pentru companii similare sau concurente
Companie EPS Diferență EPS Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 692,700.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 1,109,500.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -319,300.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -211,700.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH